All News

2020

November

Cell samples from COVID19 lung tissue analysis
Featured News / Nov 11, 2020

Study suggests there may be two stages of fatal lung disease in COVID-19

NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.

Read More
Media Release / Nov 06, 2020

Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS)

Read More
Media Release / Nov 05, 2020

Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study

Read More
Mosaic tile art
Story / Nov 04, 2020

Need for new heart disease medicines drives wave of potential therapies

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Read More
Media Release / Nov 02, 2020

Novartis announces positive results from a Phase IV study showing superior tolerability and efficacy of Aimovig® (erenumab) compared with topiramate in migraine prevention

Read More

October

Media Release / Oct 30, 2020

Novartis sickle cell medicine Adakveo® approved in Europe to prevent recurrent vaso-occlusive crises

Read More
Media Release / Oct 30, 2020

Novartis expands Kymriah® manufacturing footprint with first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia

Read More
Media Release / Oct 29, 2020

Novartis presents latest Phase III data reinforcing Cosentyx® as a first-line systemic treatment in pediatric psoriasis

Read More
Media Release / Oct 29, 2020

Novartis acquires Vedere Bio, adding novel optogenetic gene therapy technology for treating blindness

Read More
Illustration of the coronavirus created at the Centers for Disease Control and Prevention (CDC)
Featured News / Oct 28, 2020

Coronavirus (COVID-19) news feed

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.

Learn More